Kymera Therapeutics, Inc. (KYMR)

88.53 +0.46 (+0.52%) USD  |  NASDAQ  |  Apr 22, 13:22
More

Kymera Therapeutics Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade